Development and Optimization of an Unbiased, Metagenomics-Based Pathogen Detection Workflow for Infectious Disease
Kyle Parker1, Hillary Wood1, Joseph A Russell2
1MRIGlobal, 425 Dr. Martin Luther King Jr. Blvd, Kansas City, MO 64110, USA.
Tropical Medicine and Infectious Disease
|February 24, 2023
Summary
A new workflow, PanGIA (Pan-Genomics for Infectious Agents), enables rapid, comprehensive pathogen identification from clinical and environmental samples within 24 hours. This standardized approach enhances infectious disease diagnosis and biosurveillance capabilities.
Area of Science:
- Microbiology
- Genomics
- Bioinformatics
Background:
- Traditional culture methods for pathogen identification are slow.
- Molecular methods like PCR lack comprehensiveness and may miss novel strains.
- Metagenomic shotgun next-generation sequencing (NGS) offers broad, specific pathogen detection but lacks standardized workflows.
Purpose of the Study:
- To develop and assess a standardized, end-to-end workflow for rapid pathogen identification.
- To create a user-friendly bioinformatics tool for data analysis.
- To enable applications in clinical diagnostics and biosurveillance.
Main Methods:
- Developed the PanGIA (Pan-Genomics for Infectious Agents) workflow.
- Included simplified wet-lab procedures: nucleic acid extraction, host depletion, library preparation, and shotgun sequencing.
- Integrated an easy-to-use bioinformatics tool for data analysis.
- Validated with clinical whole blood and environmental swabs.
Main Results:
- The PanGIA workflow provides a sample-to-answer solution within 24 hours.
- Successfully detected bacteria and viruses from both clinical and environmental samples.
- Demonstrated specific pathogen detection for bloodstream infections and environmental surveillance.
- Workflow is compatible with Illumina MiSeq sequencing.
Conclusions:
- PanGIA offers a standardized, rapid, and comprehensive approach to pathogen detection.
- This workflow can significantly improve infectious disease diagnosis and biosurveillance.
- The system reduces reliance on targeted assay development for pathogen identification.


